| 產品詳情 |
| Edit |   |
|---|
| Product Name | PF CBP1 |
|---|
| Description | Selective CBP/p300 bromodomain inhibitor (IC50 values are 125 and 363 nM, respectively). Exhibits >100-fold selectivity for CBP over BRD4. Also exhibits selectivity over a panel of other bromodomains. Reduces LPS-induced IL-1β, IL-6 and IFN-β expression in macrophages in vitro. Also downregulates RGS4 expression in primary cortical neurons in vitro. Negative Control also available.. Purity 98%. MW (observed): 488.62 |
|---|
| Size | 10 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 5-(Dimethyl-1,2-oxazol-4-yl)-1-[2-(morpholin-4-yl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-1H-1,3-benzodiazole |
|---|
| Gene, Accession, CAS # | CAS: 1962928-21-7 |
|---|
| Catalog # | 5801/10 |
|---|
| Price | |
|---|
| Order / More Info | PF CBP1 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | n/a |
|---|
| 產品資料 |
|
|